Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis

References

• Loeffler J, Ok M, Morton OC, et al. Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation. Curr Top Microbiol Immunol. 2010;341:83–96. Epub 2010/04/17. doi:https://doi.org/10.1007/82_2010_22. PubMed PMID: 20397074.
   PubMed Web of Science ®Google Scholar
• Martinez-Laperche C, Buces E, Aguilera-Morillo MC, et al. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms. Blood Adv. 2018;2(14):1719–1737. Epub 2018/07/22. doi:https://doi.org/10.1182/bloodadvances.2017011502. PubMed PMID: 30030270; PubMed Central PMCID: PMCPMC6058238.
   PubMed Web of Science ®Google Scholar
• Hamadeh IS, Zhang Q, Steuerwald N, et al. Effect of CYP3A4, CYP3A5, and ABCB1 polymorphisms on Intravenous tacrolimus exposure and adverse events in Adult allogeneic stem cell transplant patients. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2019;25(4):656–663. Epub 2019/01/01. doi:https://doi.org/10.1016/j.bbmt.2018.12.766. PubMed PMID: 30597277.
   PubMed Web of Science ®Google Scholar
• Larsen ME, Kornblit B, Larsen MV, et al. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2010;16(10):1370–1381. Epub 2010/04/01. doi:https://doi.org/10.1016/j.bbmt.2010.03.022. PubMed PMID: 20353833.
   PubMed Web of Science ®Google Scholar
• Hansen JA, Petersdorf EW, Lin MT, et al. Genetics of allogeneic hematopoietic cell transplantation. role of HLA matching, functional variation in immune response genes. Immunol Res. 2008;41(1):56–78. Epub 2007/11/09. doi:https://doi.org/10.1007/s12026-007-0043-x. PubMed PMID: 17989941.
   PubMed Web of Science ®Google Scholar
• Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol. 2006;24:65–97. Epub 2006/03/23. doi:https://doi.org/10.1146/annurev.immunol.24.021605.090535. PubMed PMID: 16551244.
   PubMed Web of Science ®Google Scholar
• Hu P, Liu Q, Deng G, et al. The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis. Sci Rep. 2017;7:1-10, Epub 2017/02/18. doi:https://doi.org/10.1038/srep42913. PubMed PMID: 28211499; PubMed Central PMCID: PMCPMC5314410.
   Google Scholar
• Zhai JX, Zou LW, Zhang ZX, et al. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Mol Biol Rep. 2013;40(9):5213–5223. Epub 2013/08/08. doi:https://doi.org/10.1007/s11033-012-2125-7. PubMed PMID: 23922195.
   PubMed Web of Science ®Google Scholar
• Zhu CL, Huang Q, Liu CH, et al. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Mol Biol Rep. 2012;39(9):8701–8708. Epub 2012/06/20. doi:https://doi.org/10.1007/s11033-012-1727-4. PubMed PMID: 22711308.
   PubMed Web of Science ®Google Scholar
• Si X, Zhang X, Tang W, et al. Association between the CTLA-4 + 49A/G polymorphism and Graves’ disease: A meta-analysis. Exp Ther Med. 2012;4(3):538–544. Epub 2012/11/28. doi:https://doi.org/10.3892/etm.2012.618. PubMed PMID: 23181132; PubMed Central PMCID: PMCPMC3503798.
   PubMed Web of Science ®Google Scholar
• Li G, Shi F, Liu J, et al. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis. Diagn Pathol. 2014;9:157, Epub 2014/08/17. doi:https://doi.org/10.1186/s13000-014-0157-0. PubMed PMID: 25128482; PubMed Central PMCID: PMCPMC4160544.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea BJ, O’Connell D, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2014;18:727–734.
   Google Scholar
• Cochran WG. The combination ofestimates from different experiments. Biometrics. 1954;10:101–129.
   Web of Science ®Google Scholar
• Perez-Garcia A, De la Camara R, Roman-Gomez J, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007;110(1):461–467. Epub 2007/03/27. doi:https://doi.org/10.1182/blood-2007-01-069781. PubMed PMID: 17384200.
   PubMed Web of Science ®Google Scholar
• Azarian M, Busson M, Lepage V, et al. Donor CTLA-4 + 49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. Blood. 2007;110(13):4623–4624. Epub 2007/12/07. doi:https://doi.org/10.1182/blood-2007-08-106385. PubMed PMID: 18056853.
   PubMed Web of Science ®Google Scholar
• Vannucchi AM, Guidi S, Guglielmelli P, et al. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;40(10):1001–1002. Epub 2007/09/12. doi:https://doi.org/10.1038/sj.bmt.1705850. PubMed PMID: 17846597.
   PubMed Web of Science ®Google Scholar
• Piccioli P, Balbi G, Serra M, et al. CTLA-4 + 49A > G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence. Ann Hematol. 2010;89(6):613–618. Epub 2009/12/19. doi:https://doi.org/10.1007/s00277-009-0885-5. PubMed PMID: 20020126.
   PubMed Web of Science ®Google Scholar
• Sellami MH, Bani M, Torjemane L, et al. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant. Hum Immunol. 2011;72(2):139–143. Epub 2010/11/18. doi:https://doi.org/10.1016/j.humimm.2010.11.008. PubMed PMID: 21081144.
   PubMed Web of Science ®Google Scholar
• Bosch-Vizcaya A, Perez-Garcia A, Brunet S, et al. Donor CTLA-4 genotype Influences clinical outcome after T cell-Depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors. Biol Blood Marrow Transplant. 2012;18(1):100–105. doi:https://doi.org/10.1016/j.bbmt.2011.05.021. PubMed PMID: WOS:000303140200012.
   PubMed Web of Science ®Google Scholar
• Harkensee C, Oka A, Onizuka M, et al. Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: An exploration study. Blood. 2012;119(26):6365–6372. doi:https://doi.org/10.1182/blood-2012-01-406785.
   PubMed Web of Science ®Google Scholar
• Orru S, Orru N, Manolakos E, et al. Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. Hum Immunol. 2012;73(3):282–286. Epub 2012/01/17. doi:https://doi.org/10.1016/j.humimm.2011.12.014. PubMed PMID: 22245568; PubMed Central PMCID: PMCPMC3314940.
   PubMed Web of Science ®Google Scholar
• Xiao H, Luo Y, Lai X, et al. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica. 2012;97(12):1804–1812. Epub 2012/06/27. doi:https://doi.org/10.3324/haematol.2012.066159. PubMed PMID: 22733023; PubMed Central PMCID: PMCPMC3590086.
   PubMed Web of Science ®Google Scholar
• Mossallam GI, Samra MA. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation. Hum Immunol. 2013;74(12):1643–1648. Epub 2013/08/27. doi:https://doi.org/10.1016/j.humimm.2013.08.002. PubMed PMID: 23973330.
   PubMed Web of Science ®Google Scholar
• Karabon L, Markiewicz M, Partyka A, et al. A CT60G > A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation. Immunogenetics. 2015;67(5-6):295–304. Epub 2015/05/06. doi:https://doi.org/10.1007/s00251-015-0840-7. PubMed PMID: 25940108; PubMed Central PMCID: PMCPMC4427628.
   PubMed Web of Science ®Google Scholar
• Qin XY, Wang Y, Li GX, et al. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor. J Transl Med. 2016;14:100, Epub 2016/04/28. doi:https://doi.org/10.1186/s12967-016-0864-2. PubMed PMID: 27118383; PubMed Central PMCID: PMCPMC4847362.
   PubMed Web of Science ®Google Scholar
• Cunha R, Zago MA, Querol S, et al. Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation. Blood. 2017;129(4):525–532. Epub 2016/11/05. doi:https://doi.org/10.1182/blood-2016-06-722249. PubMed PMID: 27811020.
   PubMed Web of Science ®Google Scholar
• Hammrich J, Wittig S, Ernst T, et al. CTLA-4 polymorphism rs231775: influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood. Eur J Haematol. 2019;102(3):251–255. Epub 2018/11/23. doi:https://doi.org/10.1111/ejh.13200. PubMed PMID: 30465728.
   PubMed Web of Science ®Google Scholar
• Romaniuk DS, Khmelevskaya AA, Drokov MY, et al. Effect of CTLA4 gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation. Oncogematologiya. 2019;14(1):76–82. doi:https://doi.org/10.17650/1818-8346-2019-14-1-76-82.
   Google Scholar
• Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev. 2005;204:102–115. Epub 2005/03/26. doi:https://doi.org/10.1111/j.0105-2896.2005.00249.x. PubMed PMID: 15790353.
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423(6939):506–511. Epub 2003/05/02. doi:https://doi.org/10.1038/nature01621. PubMed PMID: 12724780.
   PubMed Web of Science ®Google Scholar
• Oaks MK, Hallett KM. Cutting Edge: A soluble form of CTLA-4 in patients with autoimmune Thyroid disease. The Journal of Immunology. 2000;164(10):5015, doi:https://doi.org/10.4049/jimmunol.164.10.5015.
   PubMed Web of Science ®Google Scholar